Related Experiment Video
Updated: May 15, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Colon carcinogenesis in inflammatory bowel disease
S H Itzkowitz1, B Greenwald, S J Meltzer
1Department of Medicine, Mount Sinai School of Medicine, New York City, New York; and Departments of *Medicine, and †Pathology, Oncology, and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, U.S.A.
Colon cancers in inflammatory bowel disease (IBD) show distinct molecular changes compared to sporadic cancers. Understanding these differences in colitis-associated neoplasms is key for improved patient management.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Colitis-associated neoplasms share some features with sporadic colon cancers, but molecular alterations are less understood.
- Phenotypic changes like increased sialomucin and decreased sialic acid O-acetylation correlate with malignant progression in IBD.
Purpose of the Study:
- To investigate the molecular and genetic alterations in colitis-associated colon neoplasms.
- To compare these alterations with those found in sporadic colon carcinogenesis.
Main Methods:
- Analysis of phenotypic alterations including mucin expression and sialic acid O-acetylation.
- Assessment of molecular genetic changes such as genomic instability, aneuploidy, protooncogene activation, and tumor suppressor gene mutations.
Main Results:
- Increased sialomucin and decreased sialic acid O-acetylation suggest small intestinal metaplasia during carcinogenesis.
- Genomic instability and aneuploidy are associated with malignant progression.
- Activation of k-ras, c-src and alterations in p53, APC genes occur, with potentially different timing than in sporadic cancers. Microsatellite instability is present, but mismatch repair gene mutations are not yet described.
Conclusions:
- Colitis-associated carcinogenesis involves distinct molecular and genetic pathways.
- Further research is needed to fully understand the pathobiology and guide clinical management of IBD-associated colon cancer.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations

